CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 157 filers reported holding CLOVIS ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,324,000 | -33.9% | 4,473,967 | 0.0% | 0.42% | -40.0% |
| Q2 2022 | $8,053,000 | -10.9% | 4,473,967 | 0.0% | 0.70% | +0.4% |
| Q1 2022 | $9,037,000 | -16.6% | 4,473,967 | +11.9% | 0.70% | +1.0% |
| Q4 2021 | $10,834,000 | -45.8% | 3,997,826 | -10.9% | 0.69% | -42.7% |
| Q3 2021 | $20,000,000 | -23.1% | 4,484,411 | 0.0% | 1.21% | -15.8% |
| Q2 2021 | $26,010,000 | -17.4% | 4,484,411 | 0.0% | 1.43% | -20.1% |
| Q1 2021 | $31,481,000 | +46.7% | 4,484,411 | +0.3% | 1.79% | +59.5% |
| Q4 2020 | $21,453,000 | -17.7% | 4,469,411 | 0.0% | 1.12% | -21.3% |
| Q3 2020 | $26,057,000 | -11.5% | 4,469,411 | +2.5% | 1.43% | -19.1% |
| Q2 2020 | $29,440,000 | -0.1% | 4,361,411 | -5.9% | 1.77% | -28.4% |
| Q1 2020 | $29,484,000 | -44.1% | 4,635,789 | -8.3% | 2.47% | -14.9% |
| Q4 2019 | $52,712,000 | +184.1% | 5,056,286 | +7.1% | 2.90% | +134.8% |
| Q3 2019 | $18,553,000 | -75.7% | 4,720,744 | -8.2% | 1.24% | -66.7% |
| Q2 2019 | $76,451,000 | -41.2% | 5,141,304 | -1.9% | 3.72% | -31.5% |
| Q1 2019 | $130,040,000 | +38.2% | 5,239,304 | 0.0% | 5.42% | +8.3% |
| Q4 2018 | $94,098,000 | -38.6% | 5,239,304 | +0.4% | 5.01% | -19.2% |
| Q3 2018 | $153,342,000 | -32.2% | 5,221,026 | +5.0% | 6.20% | -31.4% |
| Q2 2018 | $226,168,000 | +8.3% | 4,974,007 | +25.7% | 9.04% | +1.2% |
| Q1 2018 | $208,859,000 | -9.7% | 3,955,660 | +16.2% | 8.93% | -10.4% |
| Q4 2017 | $231,389,000 | -15.7% | 3,402,781 | +2.2% | 9.96% | -13.8% |
| Q3 2017 | $274,357,000 | -12.0% | 3,329,581 | 0.0% | 11.56% | -20.6% |
| Q2 2017 | $311,749,000 | +25.7% | 3,329,581 | -14.5% | 14.55% | +24.2% |
| Q1 2017 | $247,992,000 | +46.8% | 3,894,963 | +2.4% | 11.72% | +21.6% |
| Q4 2016 | $168,978,000 | +23.2% | 3,804,088 | 0.0% | 9.64% | +21.0% |
| Q3 2016 | $137,137,000 | +162.8% | 3,804,088 | 0.0% | 7.97% | +102.1% |
| Q2 2016 | $52,192,000 | -21.5% | 3,804,088 | +9.9% | 3.94% | -23.6% |
| Q1 2016 | $66,458,000 | -46.5% | 3,461,365 | -2.4% | 5.16% | -25.4% |
| Q4 2015 | $124,170,000 | -56.6% | 3,547,719 | +14.1% | 6.91% | -49.7% |
| Q3 2015 | $285,886,000 | +35.5% | 3,108,808 | +29.5% | 13.75% | +46.5% |
| Q2 2015 | $211,010,000 | +34.0% | 2,401,117 | +13.2% | 9.38% | +20.5% |
| Q1 2015 | $157,505,000 | +33.8% | 2,121,857 | +0.9% | 7.79% | +12.6% |
| Q4 2014 | $117,760,000 | +50.8% | 2,102,857 | +22.1% | 6.91% | +18.5% |
| Q3 2014 | $78,099,000 | +106.0% | 1,721,757 | +88.1% | 5.84% | +106.8% |
| Q2 2014 | $37,903,000 | +46.4% | 915,321 | +144.9% | 2.82% | +163.7% |
| Q1 2014 | $25,894,000 | +129.9% | 373,800 | +100.0% | 1.07% | +1.8% |
| Q4 2013 | $11,264,000 | – | 186,900 | – | 1.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,997,826 | $10,834,000 | 0.69% |
| Ikarian Capital, LLC | 1,112,669 | $3,016,000 | 0.45% |
| Versant Venture Management, LLC | 101,855 | $276,000 | 0.15% |
| Virtus ETF Advisers LLC | 60,836 | $165,000 | 0.06% |
| EMFO, LLC | 21,500 | $58,000 | 0.05% |
| QVT Financial LP | 505,000 | $1,369,000 | 0.05% |
| QVT Financial LP | 505,000 | $1,369,000 | 0.05% |
| PINNACLE ASSOCIATES LTD | 706,336 | $1,914,000 | 0.03% |
| XTX Topco Ltd | 20,920 | $57,000 | 0.03% |
| State of Wyoming | 25,419 | $69,000 | 0.03% |